Ultomiris Approved in the US for Adults with Generalised Myasthenia Gravis

Ultomiris has been approved in the US for the treatment of adult patients with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.